Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case report
Vildagliptin is a new generation theurapeutic agent of diabetes mellitus which belongs to dipeptidyl peptidase-IV inhibitor class acting via the incretin hormone system. It has moderate glycemic efficacy, a low propensity of causing hypoglycaemia and it is weight neutral. Overall, Dipeptidyl peptida...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Turaz Bilim
2018-03-01
|
| Series: | Medicine Science |
| Subjects: | |
| Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=265066 |
| _version_ | 1797328469571403776 |
|---|---|
| author | Serhat Sayin Ethem Omeroglu Semra Aslan Bilgin |
| author_facet | Serhat Sayin Ethem Omeroglu Semra Aslan Bilgin |
| author_sort | Serhat Sayin |
| collection | DOAJ |
| description | Vildagliptin is a new generation theurapeutic agent of diabetes mellitus which belongs to dipeptidyl peptidase-IV inhibitor class acting via the incretin hormone system. It has moderate glycemic efficacy, a low propensity of causing hypoglycaemia and it is weight neutral. Overall, Dipeptidyl peptidase-4 (DPP-4) inhibitors are well tolerated. The use of DPP-4 inhibitors has been associated with a slightly increased risk of upper respiratory tract infections. In this article, we report a case of cutaneous leukocytoclastic vasculitis due to probable vildagliptin usage. Vildagliptin which is associated with cutaneous leukocytoclastic vasculitis was not described in the literature before. Physical examination revealed skin rash in the abdomen and thigh region in our patients due to use of the drug. Discontinuation of the drug eliminated the skin rash immediately. [Med-Science 2018; 7(1.000): 235-237] |
| first_indexed | 2024-03-08T06:52:15Z |
| format | Article |
| id | doaj.art-a384dc58bf8f49c38228c9550d36882a |
| institution | Directory Open Access Journal |
| issn | 2147-0634 |
| language | English |
| last_indexed | 2024-03-08T06:52:15Z |
| publishDate | 2018-03-01 |
| publisher | Society of Turaz Bilim |
| record_format | Article |
| series | Medicine Science |
| spelling | doaj.art-a384dc58bf8f49c38228c9550d36882a2024-02-03T06:40:37ZengSociety of Turaz BilimMedicine Science2147-06342018-03-017123523710.5455/medscience.2017.06.8691265066Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case reportSerhat Sayin0Ethem OmerogluSemra Aslan BilginDepartment of Internal Medicine, Training and Research Hospital, Aksaray University, Aksaray, Turkey Department of Pathology, Training and Research Hospital, Health Sciences University, Konya, Turkey Department of Dermatology, Training and Research Hospital, Health Sciences University, Konya, TurkeyVildagliptin is a new generation theurapeutic agent of diabetes mellitus which belongs to dipeptidyl peptidase-IV inhibitor class acting via the incretin hormone system. It has moderate glycemic efficacy, a low propensity of causing hypoglycaemia and it is weight neutral. Overall, Dipeptidyl peptidase-4 (DPP-4) inhibitors are well tolerated. The use of DPP-4 inhibitors has been associated with a slightly increased risk of upper respiratory tract infections. In this article, we report a case of cutaneous leukocytoclastic vasculitis due to probable vildagliptin usage. Vildagliptin which is associated with cutaneous leukocytoclastic vasculitis was not described in the literature before. Physical examination revealed skin rash in the abdomen and thigh region in our patients due to use of the drug. Discontinuation of the drug eliminated the skin rash immediately. [Med-Science 2018; 7(1.000): 235-237]http://www.ejmanager.com/fulltextpdf.php?mno=265066VildagliptinVasculitisdiabetes mellitus |
| spellingShingle | Serhat Sayin Ethem Omeroglu Semra Aslan Bilgin Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case report Medicine Science Vildagliptin Vasculitis diabetes mellitus |
| title | Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case report |
| title_full | Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case report |
| title_fullStr | Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case report |
| title_full_unstemmed | Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case report |
| title_short | Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case report |
| title_sort | vildagliptin induced cutaneous leukocytoclastic vasculitis a case report |
| topic | Vildagliptin Vasculitis diabetes mellitus |
| url | http://www.ejmanager.com/fulltextpdf.php?mno=265066 |
| work_keys_str_mv | AT serhatsayin vildagliptininducedcutaneousleukocytoclasticvasculitisacasereport AT ethemomeroglu vildagliptininducedcutaneousleukocytoclasticvasculitisacasereport AT semraaslanbilgin vildagliptininducedcutaneousleukocytoclasticvasculitisacasereport |